Presidio Property Trust, Inc. (SQFT)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Model home properties | - | 915,521 | - | - |
| Office industrial properties | - | 2,854,030 | - | - |
| Retail properties | - | 262,878 | - | - |
| Total revenue | 4,378,740 | 4,125,184 | 4,723,374 | 4,586,541 |
| Gain on sales of real estate, net | - | - | 361,151 | 811,903 |
| Interest expense - mortgage notes | - | 1,510,470 | 1,473,528 | 1,525,845 |
| Net loss in conduit pharmaceuticals marketable securities (see note 9) | -7,802 | -176,658 | -3,932,770 | -10,027,433 |
| Interest expense - mortgage notes-Mortgage Notes | 1,477,870 | - | - | - |
| Income tax expense | 53,910 | -25,409 | 6,911 | 81,021 |
| Gain on sales of real estate, net | 323,359 | 4,453,968 | - | - |
| Interest and other income, net | 5,206 | 5,149 | 5,263 | 5,206 |
| Total other income (expense), net | -1,211,017 | 2,797,398 | -5,046,795 | -10,817,190 |
| Rental operating costs | 1,462,605 | 1,612,642 | 1,598,015 | 1,492,495 |
| General and administrative | 1,223,658 | 1,661,978 | 1,629,919 | 2,202,916 |
| Depreciation and amortization | 1,211,691 | 1,244,104 | 1,455,882 | 1,351,370 |
| Impairment of goodwill and real estate assets | 4,317,389 | 26,943 | - | - |
| Total costs and expenses | 8,215,343 | 4,545,667 | - | - |
| Impairment of real estate assets | - | - | 697,146 | 101,245 |
| Us-gaap_operatingexpenses | - | - | 5,380,962 | 5,148,026 |
| Net loss | -5,047,620 | 2,376,915 | -5,704,383 | -11,378,675 |
| Less income attributable to noncontrolling interests | 228,905 | 111,563 | 355,153 | 469,365 |
| Net loss attributable to presidio property trust, inc. stockholders | -5,276,525 | 2,265,352 | -6,059,536 | -11,848,040 |
| Less series d preferred stock dividends | 574,096 | 579,575 | 585,930 | 543,331 |
| Net loss attributable to presidio property trust, inc. common stockholders | -5,850,621 | 1,685,777 | -6,645,466 | -12,391,371 |
| Basic & diluted (in dollars per share) | -5.13 | 0.13 | -0.53 | -1 |
| Weighted average number of common shares outstanding - basic & dilutive (in shares) | 1,139,437 | 12,973,299 | 12,476,567 | 12,428,794 |